Escuche esta historia
--:--
3:19
They discover that two cannabis compounds prevent Covid-19
Cannabinoid acids fight even variations of infection.
Research from Oregon State University in the United States has recognized two cannabis enhancements that show the ability to prevent the infection that causes Covid-19 from entering human cells.
Hemp, experimentally referred to as Cannabis sativa, is extracted and added to products such as body creams, beauty care, food supplies, and dietary enhancements, among others.
The Journal of Natural Products published that analysts discovered that a pair of cannabinoid acids bind to the SARS-CoV-2 protein, hindering a basic advance in the process that the infection uses to contaminate individuals.
The two recognized blends are the cannabigerolic corrosive, or CBGA, and the cannabidiolic corrosive, CBDA, which were tested with the protein used in Covid-19 neutralizing treatment and immunizations.
Richard van Breemen, the creator of Cannabinoids Block Cellular Entry of SARS-CoV-2 and Emerging Variants, asserts that cannabinoid acids are numerous in hemp and excessive in hemp extracts.
These are not overpowered substances like THC, the weed's psychoactive fixation, and have a decent safety profile in people.
This exploration showed that compounds in the herb were equally viable against variations of SARS-CoV-2, including the alpha variation, which was identified in the UK, and the beta variation, first recognized in South Africa, Richard said.
Described by the crown- shaped projections molded into its outer surface, Covid-19 has RNA strands that encode its four significant underlying proteins: spike, envelope, cape, and nucleocapsid, as well as 16 nonstructural proteins and some ornament proteins.
The researcher detailed that any piece of the contamination and replication cycle is an expected target for antiviral mediation, and the association of the spike protein receptor restriction area with the human cell surface receptor ACE2 is a basic advance in that cycle.
He also indicated that this implies that cell section inhibitors, such as hemp acids, could be used to prevent contamination by SARS-CoV-2 and, in addition, to shorten diseases by preventing infection particles from staining human cells.
The analysts distinguished the two cannabinoid acids using a procedure devised in Van Breemen's lab.
The group tested various botanicals used as dietary enhancers, including wild sweet potato, red clover, hops, and three types of licorice.
In the resulting research, laboratory tests showed that cannabigerol corrosive and cannabidiol corrosive prevented contamination of human epithelial cells by the COVID-19 spike protein and prevented SARS-CoV-2 from entering cells.
The result of the examination indicates that these mixtures can be taken orally and have a long history of safe use in people. They may be able to prevent and treat SARS-CoV-2 disease.
Van Breemen argues that CBDA and CBGA are supplied by the hemp plant as a precursor to CBD and CBG, which are known to many buyers. However, they are not the same as acids and hemp products do not contain them.
